As part of our continued growth, we are pleased to announce the reintroduction of Arcinova, A Quotient Sciences Company.
Acquired by Quotient Sciences in 2021, our Alnwick, UK site has been a valued part of our business for the last four years, providing integrated drug substance, bioanalysis, isotope labelling, and related services that have complemented our capabilities.
Arcinova offers solutions tailored for early development, from candidate selection through to proof of concept. This means faster, more efficient development pathways, deeper scientific expertise and expanded access to specialized services to help you bring innovative therapies to patients sooner.
How Arcinova and Quotient Sciences work together
Collectively, our two brands, Quotient Sciences and Arcinova, provide complementary services for the full drug development pathway.
From facilities in Reading and Alnwick, UK, Arcinova delivers integrated drug substance and drug product capabilities from candidate selection to Phase II trials, along with bioanalysis, isotope labelling, microbiology, inhaled drug product development, and aseptic manufacturing. Arcinova also continue to partner with Charles River to support integrated services for candidate selection.
Quotient Sciences Nottingham and Edinburgh, UK and Philadelphia, PA and Miami, FL, US continues to offer services that include integrated Translational Pharmaceutics® programmes, a range of clinical pharmacology studies (e.g. SAD/MAD, FIH, DDI), and drug product services including formulation, clinical, and commercial manufacturing.
What has changed for Arcinova:
- A new website for Arcinova is now available, www.arcinova.com.
- Arcinova commercial, scientific and leadership teams may be in contact with you, in addition to representatives from Quotient Sciences' teams.
- New communications materials and channels are available, including info@arcinova.com for general enquiries.
- Colleagues supporting the Arcinova brand, such as business development and drug development consultants, will begin to use arcinova.com as their email sending domain. (Emails sent to quotientsciences.com addresses will continue to work.)
What hasn’t changed for Arcinova:
- Arcinova remains part of the larger Quotient Sciences ownership structure.
- No changes have been made at this time to purchasing, quality, or IT systems.
- Customer numbers remain the same for billing/invoicing in addition to project codes.
Our shared commitment
While this brand re-introduction reflects an evolution to offer more clearly defined service structure and delivery for our customers, both Arcinova and Quotient Sciences continue to share the same commitment to deep science, agility, flexibility, and customer service excellence as before.
We are privileged to work on some of the most exciting drugs in the industry pipeline, advancing new drug candidates through early development and beyond. We value your feedback and partnership: Reach out to your Quotient Sciences or Arcinova representatives if you have specific questions about these changes.